Missed GME or NVDA? Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
PX Stock Forecast 2025-2026
$12.13
Current Price
$1.37B
Market Cap
Buy 3
Hold 1
Sell 0
Wall St Analyst Ratings
Distance to PX Price Targets
+64.9%
To High Target of $20.00
+17.5%
To Median Target of $14.25
+7.2%
To Low Target of $13.00
PX Price Momentum
+4.0%
1 Week Change
+10.1%
1 Month Change
+47.4%
1 Year Change
-3.8%
Year-to-Date Change
-15.1%
From 52W High of $14.28
+53.9%
From 52W Low of $7.88
📉 MARKET SELLOFF ALERT
10 Quality Stocks Worth Considering Now
Researching P10 (PX) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on PX and similar high-potential opportunities.
Latest PX Stock Price Targets & Analyst Predictions
Based on our analysis of 14 Wall Street analysts, PX has a bullish consensus with a median price target of $14.25 (ranging from $13.00 to $20.00). The overall analyst rating is Strong Buy (8.0/10). Currently trading at $12.13, the median forecast implies a 17.5% upside. This outlook is supported by 3 Buy, 1 Hold, and 0 Sell ratings.
Conversely, the most conservative target is provided by Benjamin Budish at Barclays, suggesting a 7.2% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
PX Analyst Ratings
3
Buy
1
Hold
0
Sell
PX Price Target Range
Low
$13.00
Average
$14.25
High
$20.00
Current: $12.13
Latest PX Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for PX.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| May 13, 2025 | JP Morgan | Kenneth Worthington | Overweight | Maintains | $14.50 |
| May 9, 2025 | Barclays | Benjamin Budish | Overweight | Maintains | $14.00 |
| Apr 14, 2025 | Morgan Stanley | Michael Cyprys | Equal-Weight | Maintains | $12.00 |
| Apr 7, 2025 | Barclays | Benjamin Budish | Overweight | Maintains | $13.00 |
| Feb 13, 2025 | Barclays | Benjamin Budish | Overweight | Maintains | $15.00 |
| Feb 13, 2025 | Stephens & Co. | John Campbell | Overweight | Maintains | $16.00 |
| Jan 13, 2025 | Barclays | Benjamin Budish | Overweight | Maintains | $16.00 |
| Jan 7, 2025 | JP Morgan | Kenneth Worthington | Overweight | Upgrade | $15.00 |
| Dec 12, 2024 | Oppenheimer | Chris Kotowski | Outperform | Maintains | $21.00 |
| Dec 9, 2024 | Barclays | Benjamin Budish | Overweight | Maintains | $15.00 |
| Nov 12, 2024 | JP Morgan | Kenneth Worthington | Neutral | Maintains | $14.00 |
| Nov 11, 2024 | Morgan Stanley | Michael Cyprys | Equal-Weight | Maintains | $13.00 |
| Nov 11, 2024 | Stephens & Co. | John Campbell | Overweight | Maintains | $13.00 |
| Nov 8, 2024 | Keefe, Bruyette & Woods | Kyle Voigt | Market Perform | Reiterates | $13.00 |
| Oct 22, 2024 | UBS | Adam Beatty | Neutral | Maintains | $12.00 |
| Oct 16, 2024 | Oppenheimer | Chris Kotowski | Outperform | Maintains | $16.00 |
| Oct 10, 2024 | Morgan Stanley | Michael Cyprys | Equal-Weight | Maintains | $12.00 |
| Oct 7, 2024 | Barclays | Benjamin Budish | Overweight | Maintains | $12.00 |
| Aug 21, 2024 | UBS | Adam Beatty | Neutral | Downgrade | $10.50 |
| Aug 14, 2024 | Morgan Stanley | Michael Cyprys | Equal-Weight | Maintains | $10.00 |
P10 Inc. (PX) Competitors
The following stocks are similar to P10 based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
P10 Inc. (PX) Financial Data
P10 Inc. has a market capitalization of $1.37B with a P/E ratio of 76.4x. The company generates $298.00M in trailing twelve-month revenue with a 6.1% profit margin.
Revenue growth is +2.3% quarter-over-quarter, while maintaining an operating margin of +28.2% and return on equity of +4.9%.
Valuation Metrics
Market Cap
$1.37B
Enterprise Value
$1.72B
P/E Ratio
76.4x
PEG Ratio
13.0x
Price/Sales
4.6x
Growth & Margins
Revenue Growth (YoY)
+2.3%
Gross Margin
+45.2%
Operating Margin
+28.2%
Net Margin
+6.1%
EPS Growth
-9.9%
Financial Health
Cash/Price Ratio
+5.5%
Current Ratio
1.9x
Debt/Equity
102.3x
ROE
+4.9%
ROA
+7.2%
💰 DON'T MISS THIS OPPORTUNITY
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
P10 Inc. (PX) Business Model
About P10 Inc.
What They Do
Provides capital to lower middle-market private equity firms.
Business Model
The company operates as an alternative asset management firm, generating revenue by offering diversified investment strategies and specialized finance solutions through its subsidiary brands. It caters to institutional and high-net-worth investors looking for exposure to private equity, venture capital, and impact investing. By strategically investing in businesses at critical stages, it seeks to deliver reliable returns while managing risks effectively.
Additional Information
P10 Inc. focuses on sectors like private equity and venture capital, contributing to economic expansion and innovation. Its reputation for consistent performance enhances its attractiveness to potential investors.
Company Information
Sector
Financial Services
Industry
Asset Management
Employees
267
CEO
Mr. Luke A. Sarsfield III
Country
United States
IPO Year
2021
Website
www.p10alts.comP10 Inc. (PX) Latest News & Analysis
Featured Analysis
Powered by
Zacks Investment Research
Core Scientific, Inc. (CORZ) Reports Q1 Loss, Misses Revenue Estimates
Core Scientific, Inc. (CORZ) delivered earnings and revenue surprises of 16.67% and 8.11%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
May 07, 2025
By Zacks Equity Research
Tale of the Tape
Latest News
Quick Summary
P10, Inc. (NYSE: PX) will hold its Q1 2025 Earnings Conference Call on May 8, 2025, at 8:30 AM ET, featuring key executives and analysts from major firms.
Why It Matters
P10, Inc.'s Q1 earnings call provides insights into its financial performance and strategic direction, influencing stock valuations and investor confidence.
Source: Seeking Alpha
Market Sentiment:
Neutral
P10 Reports First Quarter 2025 Earnings Results
10 days ago
Quick Summary
P10, Inc. (NYSE: PX) reported Q1 2025 revenue of $67.7M (up 2% YoY), raised its quarterly dividend by 7%, and raised over $1.4B in new fee-paying AUM. Acquisition of Qualitas Funds completed.
Why It Matters
Record fundraising boosts AUM, indicating strong demand. Increased dividends signal confidence in cash flow, while revenue growth shows stability, all of which enhance investment attractiveness.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
P10 (PX) reported its revenue and EPS for Q1 2025. Investors should compare these figures with Wall Street estimates and year-ago metrics for a comprehensive analysis.
Why It Matters
Revenue and EPS figures for P10 (PX) will influence investor sentiment, as comparisons to Wall Street estimates and past performance indicate growth potential or weaknesses.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
P10, Inc. (PX) reported quarterly earnings of $0.20 per share, missing the Zacks Consensus Estimate of $0.21, down from $0.21 per share year-over-year.
Why It Matters
P10, Inc. missed earnings expectations, signaling potential operational issues or declining performance, which may negatively impact stock prices and investor confidence.
Source: Zacks Investment Research
Market Sentiment:
Negative
Quick Summary
P10 (PX) lacks the essential factors for a potential earnings beat in its upcoming report, indicating cautious expectations for investors.
Why It Matters
P10 (PX) may underperform in its earnings report due to lacking key ingredients for a beat, potentially impacting stock performance and investor sentiment.
Source: Zacks Investment Research
Market Sentiment:
Neutral
P10 Announces Appointments of Jennifer Glassman and Stephen Blewitt to Board of Directors
27 days ago
Quick Summary
P10, Inc. (NYSE: PX) appointed Jennifer Glassman and Stephen Blewitt to its Board of Directors, effective April 21, 2025. Glassman will join the Audit Committee, Blewitt the Compensation Committee.
Why It Matters
The appointment of independent directors enhances governance, potentially boosting investor confidence and impacting company performance positively.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Frequently Asked Questions About PX Stock
What is P10 Inc.'s (PX) stock forecast for 2025?
Based on our analysis of 14 Wall Street analysts, P10 Inc. (PX) has a median price target of $14.25. The highest price target is $20.00 and the lowest is $13.00.
Is PX stock a good investment in 2025?
According to current analyst ratings, PX has 3 Buy ratings, 1 Hold ratings, and 0 Sell ratings. The stock is currently trading at $12.13. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for PX stock?
Wall Street analysts predict PX stock could reach $14.25 in the next 12 months. This represents a 17.5% increase from the current price of $12.13. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is P10 Inc.'s business model?
The company operates as an alternative asset management firm, generating revenue by offering diversified investment strategies and specialized finance solutions through its subsidiary brands. It caters to institutional and high-net-worth investors looking for exposure to private equity, venture capital, and impact investing. By strategically investing in businesses at critical stages, it seeks to deliver reliable returns while managing risks effectively.
What is the highest forecasted price for PX P10 Inc.?
The highest price target for PX is $20.00 from at , which represents a 64.9% increase from the current price of $12.13.
What is the lowest forecasted price for PX P10 Inc.?
The lowest price target for PX is $13.00 from Benjamin Budish at Barclays, which represents a 7.2% increase from the current price of $12.13.
What is the overall PX consensus from analysts for P10 Inc.?
The overall analyst consensus for PX is bullish. Out of 14 Wall Street analysts, 3 rate it as Buy, 1 as Hold, and 0 as Sell, with a median price target of $14.25.
How accurate are PX stock price projections?
Stock price projections, including those for P10 Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: May 18, 2025 6:27 PM UTC